Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.1%

2 terminated/withdrawn out of 22 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

0%

0 of 18 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
17(81.0%)
Phase 3
2(9.5%)
Phase 2
1(4.8%)
N/A
1(4.8%)
21Total
Phase 1(17)
Phase 3(2)
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT06761066Not ApplicableNot Yet Recruiting

Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Role: lead

NCT05856487Phase 3Unknown

To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

Role: lead

NCT05725252Phase 1Completed

To Evaluate the Safety and the Pharmacokinetics of NVP-2203

Role: lead

NCT04961905Phase 1Completed

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

Role: lead

NCT05354713Phase 1Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

Role: lead

NCT05141110Phase 1Completed

Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects

Role: lead

NCT04905342Phase 1Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers

Role: lead

NCT05023031Phase 1Completed

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

Role: lead

NCT04082975Phase 3Completed

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

Role: lead

NCT04780386Phase 1Completed

Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2

Role: lead

NCT04181437Phase 1Completed

Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2

Role: lead

NCT03802526Phase 1Completed

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

Role: lead

NCT03341832Phase 2Completed

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

Role: lead

NCT02289274Phase 1Withdrawn

Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

Role: lead

NCT03220399Phase 1Withdrawn

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2

Role: lead

NCT02289404Phase 1Completed

A Study to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203

Role: lead

NCT03340480Phase 1Completed

The Food Effect on the Pharmacokinetics of NVP-1402

Role: lead

NCT02897726Phase 1Completed

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

Role: lead

NCT02029625Phase 1Completed

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

Role: lead

NCT01885520Phase 1Completed

Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg

Role: lead